ClinicalTrials.gg
Enrolling by invitationNCT07318090F-PGTUpdated Jul 15, 2026

F-PGT - Prolonged Grief Treatment for Families Affected by Suicide

An interventional study of F-PGT in Prolonged Grief Disorder (PGD), sponsored by University of Pittsburgh. Enrolling by invitation at 2 sites in United States. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
8 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Prolonged Grief Disorder with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Prolonged Grief Disorder · United States.

Planned enrollment
10th of 14
30 · median 42
Started
2025
with 1 other
No phase
10 of 15
3 open now
Registered
13th of 15
by date
Lead sponsor
1 of 15
University of Pittsburgh

Among the 15 studies in Prolonged Grief Disorder with a site in United States, this one is the 10th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2025, is one of 10 with no phase, and was the 13th registered.

Prolonged Grief Disorder

40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.

Browse Prolonged Grief Disorder studies →

Open to participants now

4 of the 15 studies in Prolonged Grief Disorder with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Prolonged Grief Disorder studies recruiting now, 7 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 8 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Prolonged Grief Disorder with a site in United States, or all of them as a file.
02

Study summary

This pilot open trial is being done to better understand the needs of families who have lost a parent to suicide at least a year ago and who have children ages 8-14 and to develop and test Family-Prolonged Grief Treatment (F-PGT), a modification of prolonged grief therapy (PGT) as a way to help these families. PGT has been proven efficacious for adults with prolonged grief. The therapy has been adapted to include work with parents in helping their children (aged 8-14) and to include sessions with the child. All assessment and treatment sessions of the study are being conducted virtually.

Read the detailed description

Interested potential adult participants will first complete a preliminary screening conducted by phone or secure zoom. Eligible and interested families will meet with a study clinician to provide written informed consent and child assent to participate in a 2-step study process. Step 1 is baseline assessment and confirming study eligibility, and step 2 is Prolonged Grief Treatment for Families (F-PGT).

Families who give consent will complete assessments to confirm eligibility for the study. Those who are not eligible will conclude their study participation. Eligible families will complete the remaining baseline assessments and proceed to step 2, treatment.

F-PGT includes 16 virtual sessions where a therapist will meet with either the parent or child, or both. All sessions will be recorded to continue optimize the therapy.

In addition, participants will complete regular assessments.

03

Conditions studied

  • Prolonged Grief Disorder (PGD)

Keywords

  • Prolonged Grief Disorder
  • Suicide loss survivor
  • Family treatment
  • Prolonged Grief Treatment
  • Grief
04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parental suicide bereaved children aged 8-14 years and their parents or caregivers.
  • Child score of 68 or higher on the Inventory for Complicated Grief-Revised for Children (ICG-RC) and/or parent score of 5 or higher on the Brief Grief Questionnaire at phone screen and score of 30 or higher on the Inventory for Complicated Grief (ICG) at baseline.
  • At least 12 months after death.
  • Child and/or parent's primary concern is prolonged grief
  • Child has a biological/adoptive parent or court-appointed guardian who can present paperwork that they are able to consent for research for the youth involved in the study. Child is currently living with this caregiver and has spent most of their time in the past year under their care.
  • Both child and parent/caregiver have a clinical provider to communicate safety concerns (e.g., primary care provider, pediatrician)
  • Both child and parent/caregiver live in the United States
  • If taking psychoactive medications, has been on a stable dose for at least 3 months.

Exclusion criteria

Exclusion Criteria:

Youth exclusion criteria:

  • Limited cognitive abilities to assent or to participate in the therapy (e.g., acute mania, psychosis, severe autism spectrum disorder)
  • Unstable serious medical condition
  • Current residence is in a state in which none of the study therapists are licensed (i.e., Alaska, Hawaii, Iowa, Louisiana, Massachusetts, Montana, New Mexico, Oregon)
  • Has a substance use disorder (determined by KSADS during the baseline assessment)
  • Is currently in therapy and unwilling to pause it for the study duration, or begins therapy during the period of study participation
  • Those with active suicidality (C-SSRS scores of 3 or higher)
  • Those who report any suicidal behaviors in the past year (i.e., suicide attempt, interrupted attempt, aborted attempt, preparatory behaviors), including any formal crisis management in the past year (e.g., presented at emergency department for suicidality), as assessed at baseline.

Parent/Caregiver Exclusion criteria:

  • Age younger than 18 years old
  • Limited cognitive abilities to consent (e.g., acute mania, psychosis)
  • Unstable serious medical condition
  • For those with active suicidality (C-SSRS scores of 3 or higher), eligibility will be determined by the clinical team and PIs based on prior history of suicidality, access to lethal means, availability social support, reasons for living, and engagement in safety planning.
  • Those who report any suicidal behaviors in the past year (i.e., suicide attempt, interrupted attempt, aborted attempt, preparatory behaviors), including any formal crisis management in the past year (e.g., presented at emergency department for suicidality), as assessed at baseline.
  • Is currently in therapy and unwilling to pause it for the study duration, or begins therapy during the study duration
  • Current residence is in a state in which none of the study therapists are licensed (i.e., Alaska, Hawaii, Iowa, Louisiana, Massachusetts, Montana, New Mexico, Oregon)
  • Has a substance use disorder (determined by SCID during the baseline assessment)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    F-PGT

    Eligible families will receive 16 online sessions of Family-Prolonged Grief Treatment (F-PGT).

    Behavioral: F-PGT

Interventions

  • BehavioralF-PGT

    Family- Prolonged Grief Treatment (F-PGT) is a specialized talk therapy to help families who have lost a parent to suicide. It is based on Prolonged Grief Therapy (PGT) that is efficacious for adults and is now adapted for parents and their children ages 8 to 14. The therapy includes 16 online sessions where a therapist meets with the parent alone, the child alone, or both together. Activities for children are designed to match their age and understanding. The therapy guides families through six steps: understanding and accepting grief, seeing promise in the future, strengthening relationships, sharing the story of the death, living with reminders, and connecting with memories. As a part of the focus on strengthening relationships parents are encouraged to invite a friend or relative to join a session.

06

What researchers measure

Primary outcomes

  1. Total Score on Feasibility of Intervention Measure (FIM) at End of Treatment

    Total scores from the Feasibility of Intervention Measure (FIM) will be used to assess participants' perception of intervention feasibility. Total Score FIM: 4-8 Low feasibility; 9-15 Moderate feasibility; 16-20 High feasibility.

    Time frame: End of treatment at 20 weeks

  2. Total Score on Acceptability of Intervention Measure (AIM) at End of Treatment

    Total scores from the Acceptability of Intervention Measure (AIM) will be used to assess participants' perception of intervention acceptability. Total Score AIM: 4-8 Low acceptability; 9-15 Moderate acceptability; 16-20 High acceptability.

    Time frame: End of treatment at 20 weeks

  3. Change in Inventory of Complicated Grief (ICG) Total Score

    Total scores from the Inventory of Complicated Grief (ICG) will be used to assess severity of complicated grief symptoms in adults. Total Score ICG: 0-24 Minimal grief; 25-29 Mild/moderate grief; ≥30 Clinically significant grief.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  4. Change in Inventory for Complicated Grief-Revised for Children (ICG-RC) Total Score

    Total scores from the Inventory for Complicated Grief-Revised for Children (ICG-RC) will be used to assess severity of prolonged grief symptoms in children and adolescents. Total Score ICG-RC: 28-67 Minimal/mild grief; ≥68 Clinically significant prolonged grief.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  5. Change in Clinical Global Impression (CGI-S and CGI-I) Scores

    Clinician-rated scores from the Clinical Global Impression scale will be used to assess global severity and improvement. CGI-Severity: 1-2 Normal/mild; 3-4 Moderate; 5-7 Severe. CGI-Improvement: 1-2 Improved; 3-4 No change; 5-7 Worsened.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

Secondary outcomes

  1. Change in Child Global Assessment Scale (C-GAS) Total Score

    Total scores from the Children's Global Assessment Scale (C-GAS) will be used to assess overall child functioning. Total Score C-GAS: 91-100 Superior functioning; 71-90 Good functioning; 51-70 Moderate impairment; 31-50 Serious impairment; 1-30 Severe impairment.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  2. Change in Global Assessment Scale (GAS) Total Score (Parent)

    Total scores from the Global Assessment Scale (GAS) will be used to assess overall parental functioning. Higher scores indicate better functioning.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  3. Change in Work and Social Adjustment Scale (WSAS) Total Score

    Total scores from the Work and Social Adjustment Scale (WSAS) will be used to assess functional impairment. Total Score WSAS: 0-9 Low impairment; 10-20 Significant impairment; \>20 Moderately severe to severe impairment.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  4. Change in Parental Reflective Functioning Questionnaire (PRFQ) Total Score

    Total scores from the Parental Reflective Functioning Questionnaire (PRFQ) will be used to assess parents' capacity to reflect on their child's mental states. Higher scores indicate greater reflective functioning, except for the Pre-mentalizing subscale where higher scores indicate less adaptive functioning.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  5. Change in Coping with Children's Negative Emotions Scale (CCNES) Total Score

    Total scores from the Coping with Children's Negative Emotions Scale (CCNES) will be used to assess parental responses to children's negative emotions. Higher supportive response scores reflect more adaptive parenting.

    Time frame: Baseline; 20 weeks assessment

  6. Change in Child and Adolescent Reflective Functioning Scale (CARFS) Score

    Total scores from the Child and Adolescent Reflective Functioning Scale (CARFS) will be used to assess children's ability to understand their own and others' mental states. Higher scores indicate greater reflective functioning.

    Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment

  7. Change in Child-Parent Relationship Scale (CPRS) Total Score

    Total scores from the Child-Parent Relationship Scale (CPRS) will be used to assess parent-child relationship quality. Higher scores indicate more positive relationship quality or greater stress on stress-related subscales.

    Time frame: Baseline; 4 weeks; 12 weeks; 20 weeks assessment

  8. Presence of Psychiatric Diagnoses as Assessed by Structured Clinical Interview for DSM-5 (SCID-5)

    Diagnostic outcomes from the Structured Clinical Interview for DSM-5 (SCID-5) will be used to assess the presence of DSM-5 psychiatric disorders in adults for inclusion/exclusion criteria and will help in assessing global functioning. Each disorder will be coded as 0 (not present), 1 (subthreshold), or 2 (present).

    Time frame: Baseline

  9. Change in Psychiatric Diagnoses as Assessed by Structured Clinical Interview for DSM-5 (SCID-5)

    Diagnostic outcomes from the Structured Clinical Interview for DSM-5 (SCID-5) will be used to assess changes in DSM-5 psychiatric disorders in adults and in global functioning. Each disorder will be coded as 0 (not present), 1 (subthreshold), or 2 (present).

    Time frame: End of treatment at 20 weeks

  10. Presence of Psychiatric Diagnoses as Assessed by K-SADS-PL (Child and Parent Versions)

    Diagnostic outcomes from the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) will be used to assess DSM psychiatric disorders in children and adolescents for inclusion/exclusion criteria and will help in assessing global functioning. Each disorder will be coded as 1 (not present), 2 (subthreshold), or 3 (present).

    Time frame: Baseline; 20 weeks assessment

  11. Change in DSM Psychiatric Diagnoses as Assessed by Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL)

    Diagnostic outcomes from the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) will be used to assess changes in DSM psychiatric disorders in children and adolescents and in global functioning. Each disorder will be coded as 1 (not present), 2 (subthreshold), or 3 (present).

    Time frame: End of treatment at 20 weeks

  12. Total Score on Prolonged Grief Disorder-13 (PG-13) Scale

    Total scores from the Prolonged Grief Disorder-13 (PG-13) scale will be used to assess severity of prolonged grief symptoms. Total Score PG-13: 10-29 Mild grief; 30-50 Clinically significant prolonged grief.

    Time frame: Baseline

  13. Change in Total Score on Prolonged Grief Disorder-13 (PG-13) Scale

    Total scores from the Prolonged Grief Disorder-13 (PG-13) scale will be used to assess severity of prolonged grief symptoms. Total Score PG-13: 10-29 Mild grief; 30-50 Clinically significant prolonged grief.

    Time frame: 20 weeks assessment

  14. Observed Parent-Child Communication Behaviors During Virtual Interaction Tasks

    Observed parent-child communication behaviors will be assessed during three 5-minute structured virtual interaction tasks (discussion of friendships, resolution of a minor conflict, and planning a "dream vacation"). Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Higher scores indicate more adaptive communication behaviors.

    Time frame: Baseline

  15. Change in Observed Parent-Child Communication Behaviors During Virtual Interaction Tasks

    Change in observed parent-child communication behaviors will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Positive change scores indicate improvement in communication behaviors from baseline.

    Time frame: End of treatment at 20 weeks

  16. Observed Parent-Child Attachment Behaviors During Virtual Interaction Tasks

    Observed attachment-related behaviors between parent and child will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Higher scores indicate more secure attachment behaviors.

    Time frame: Baseline

  17. Change in Observed Parent-Child Attachment Behaviors During Virtual Interaction Tasks

    Change in observed parent-child attachment behaviors will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Positive change scores indicate improvement in attachment behaviors from baseline.

    Time frame: End of treatment at 20 weeks

  18. Observed Parent and Child Reflective Functioning During Virtual Interaction Tasks

    Observed reflective functioning of parents and children will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained staff using a validated reflective functioning coding framework. Higher scores indicate greater capacity to recognize and interpret mental states.

    Time frame: Baseline

  19. Change in Observed Parent and Child Reflective Functioning During Virtual Interaction Tasks

    Change in observed reflective functioning of parents and children will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained staff using a validated reflective functioning coding framework. Positive change scores indicate improvement in reflective functioning from baseline.

    Time frame: End of treatment at 20 weeks

Other outcomes

  1. Change in Depressive Symptoms as Assessed by Quick Inventory of Depressive Symptomatology (QIDS)

    Total scores from the Quick Inventory of Depressive Symptomatology (QIDS) will be used to assess depressive symptom severity. Higher scores indicate greater depression severity.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

  2. Change in Anxiety Symptoms as Assessed by Generalized Anxiety Disorder-7 (GAD-7)

    Total scores from the Generalized Anxiety Disorder-7 (GAD-7) will be used to assess anxiety severity. Higher scores indicate greater anxiety.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

  3. Change in Posttraumatic Stress Symptoms as Assessed by Davidson Trauma Scale (DTS)

    Total scores from the Davidson Trauma Scale (DTS) will be used to assess severity of posttraumatic stress symptoms. Higher scores indicate greater trauma-related distress.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

  4. Change in Child Anxiety and Depression Symptoms as Assessed by RCADS-25 (Child and Parent Versions)

    Total scores from the Revised Children's Anxiety and Depression Scale - Short Version (RCADS-25) will be used to assess anxiety and depressive symptoms in children and adolescents. Higher scores indicate greater symptom severity.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

  5. Suicidal Ideation and Behavior as Assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)

    Scores from the Columbia-Suicide Severity Rating Scale (C-SSRS) will be used to assess severity and frequency of suicidal ideation and behavior in adults and children. The C-SSRS ideation severity subscale is scored on a 5-point ordinal scale ranging from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating greater severity of suicidal ideation and a worse clinical outcome.

    Time frame: Baseline; weekly during treatment; 20 weeks assessment

  6. Change in Family Functioning as Assessed by Family Adaptability and Cohesion Scale (FACES-IV-SF)

    Total scores from the Family Adaptability and Cohesion Scale - Short Form (FACES-IV-SF) will be used to assess family functioning. Higher scores indicate healthier family dynamics.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

  7. Change in Parenting Competence as Assessed by Parenting Sense of Competency Scale (PSCS)

    Total scores from the Parenting Sense of Competency Scale (PSCS) will be used to assess parental efficacy and satisfaction. Higher scores indicate greater perceived parenting competence.

    Time frame: Baseline; 12 weeks; 20 weeks assessment

07

Study locations

2 sites
08

References and documents

Publications

  • Melhem NM, Walker M, Moritz G, Brent DA. Antecedents and sequelae of sudden parental death in offspring and surviving caregivers. Arch Pediatr Adolesc Med. 2008 May;162(5):403-10. doi: 10.1001/archpedi.162.5.403. PubMed 18458185 ↗
  • Melhem NM, Porta G, Shamseddeen W, Walker Payne M, Brent DA. Grief in children and adolescents bereaved by sudden parental death. Arch Gen Psychiatry. 2011 Sep;68(9):911-9. doi: 10.1001/archgenpsychiatry.2011.101. PubMed 21893658 ↗
  • Hamdan S, Mazariegos D, Melhem NM, Porta G, Payne MW, Brent DA. Effect of parental bereavement on health risk behaviors in youth: a 3-year follow-up. Arch Pediatr Adolesc Med. 2012 Mar;166(3):216-23. doi: 10.1001/archpediatrics.2011.682. PubMed 22393180 ↗
  • Pham S, Porta G, Biernesser C, Walker Payne M, Iyengar S, Melhem N, Brent DA. The Burden of Bereavement: Early-Onset Depression and Impairment in Youths Bereaved by Sudden Parental Death in a 7-Year Prospective Study. Am J Psychiatry. 2018 Sep 1;175(9):887-896. doi: 10.1176/appi.ajp.2018.17070792. Epub 2018 Jun 20. PubMed 29921145 ↗
  • Melhem NM, Porta G, Walker Payne M, Brent DA. Identifying prolonged grief reactions in children: dimensional and diagnostic approaches. J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):599-607.e7. doi: 10.1016/j.jaac.2013.02.015. Epub 2013 Apr 24. PubMed 23702449 ↗
  • Melhem NM, Moritz G, Walker M, Shear MK, Brent D. Phenomenology and correlates of complicated grief in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):493-499. doi: 10.1097/chi.0b013e31803062a9. PubMed 17420684 ↗
  • Shear K, Frank E, Houck PR, Reynolds CF 3rd. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005 Jun 1;293(21):2601-8. doi: 10.1001/jama.293.21.2601. PubMed 15928281 ↗
  • Shear MK, Wang Y, Skritskaya N, Duan N, Mauro C, Ghesquiere A. Treatment of complicated grief in elderly persons: a randomized clinical trial. JAMA Psychiatry. 2014 Nov;71(11):1287-95. doi: 10.1001/jamapsychiatry.2014.1242. PubMed 25250737 ↗
  • Shear MK, Reynolds CF 3rd, Simon NM, Zisook S, Wang Y, Mauro C, Duan N, Lebowitz B, Skritskaya N. Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Jul 1;73(7):685-94. doi: 10.1001/jamapsychiatry.2016.0892. PubMed 27276373 ↗
  • Hamdan S, Melhem NM, Porta G, Song MS, Brent DA. Alcohol and substance abuse in parentally bereaved youth. J Clin Psychiatry. 2013 Aug;74(8):828-33. doi: 10.4088/JCP.13m08391. PubMed 24021502 ↗

Individual participant data

Plan to share: No — Not required by the funding agency.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.

Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2025
First posted
Jan 5, 2026
StartActual
Dec 17, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07318090
Collaborators
American Foundation for Suicide Prevention, Columbia University
Responsible party
Nadine Melhem (Professor, University of Pittsburgh) — Principal investigator
First posted
Jan 5, 2026
Start date
Dec 17, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 15, 2026

Study contacts

Nadine A Melhem, PhD
principal investigator · University of Pittsburgh
M. Katherine Shear, MD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion